Lymphoid Malignancy Flashcards
What is leukaemia cancers of?
Lymphoid origin
Presentation of leukaemia
Enlarged lymph nodes (lymphadenopathy) OR with extranodal involvement OR with bone marrow involvement Systemic symptoms - weight loss (>10% in 6 months) - fever - night sweats - pruritis - fatigue
What test tells us the type of leukaemia?
Biopsy (lymph node, bone marrow etc)
What test tells us where the leukaemia is?
Clinical exam
imaging (e.g. CT)
What is a broad difference of Hodgkin Lymphoma vs Non-Hodgkin Lymphoma?
Hodgkin = specific disease
Non - Hodgkin = everything else (approx. 50 subtypes)
Lymphoproliferative disorders
Acute lymphoblastic leukaemia (ALL)
Chronic lymphocytic leukaemia (CLL)
Hodgkin Lymphoma
Non-Hodgkin Lymphoma (NHL)
Types of Non-Hodgkin Lymphoma (NHL)
High grade
- diffuse large B cell lymphoma
Low grade
- follicular, marginal zone
What is acute lymphoblastic leukaemia (ALL)?
Neoplastic disorder of lymphoblasts
How is ALL diagnosed?
By > 20% lymphoblasts present in bone marrow
Who does 75% of cases of ALL occur in?
Children < 6 y/o
How much of ALL is B cell lineage?
75-90%
Presentation of ALL
2-3 week history of bone marrow failure +/- raised white cell count or bone/joint pain
Infection
Sweats
Treatment of ALL
Induction chemo to obtain remission Consolidation therapy CNS directed treatment Maintenance therapy for 18 months Allogenic stem cell transplantation (if HIGH RISK) newer therapies - Bispecific T cell engagers - CAR
S/Es of T cell immunotherapy
Cytokine release syndrome
Neurotoxicity
Presentation of cytokine release syndrome
Fever
Hypotension
Dyspnoea
Presentation of neurotoxicity
Confusion with normal conscious level seizure headache focal neurology coma
Poor risk factors for ALL
Increasing age increased WCC immunophenotyped (more primitive forms) Cytogenetics/molecular genetics (t(9;22), t(4;11)) Slow/poor response to treatment
Prognosis of ALL
Adults - complete remission 78-91% - leukaemia free survival a 5 y - 30-35% Children - 5 yr overall survival 90% - Poor risk patients (slow response to induction or Philadelphia positive) 5 yr overall survival 45%
What is the commonest leukaemia worldwide?
Chronic Lymphocytic Leukaemia (CLL)
Which gender gets CLL?
M > F 2:1
Where is CLL rare?
Far east
Presentation of CLL
Often asymptomatic at presentation Bone marrow failure - anaemia - thrombocytopenia Lymphadenopathy Splenomegaly (30%) Fever and sweats (<25%) Hepatomegaly
Diagnosis of CLL
Blood > 5 x10 9/L lymphocytes Bone marrow > 30% lymphocytes Characteristic immunophenotyping - B cell markers (CD 19, 20, 23) - CD5 positive
Associated findings of CLL
Immune Paresis (loss of normal immunoglobulin production) Haemolytic anaemia